COMMUNIQUÉS West-GlobeNewswire

L’Agence des médicaments du Canada émet une recommandation favorable au remboursement d’EMPAVELI (pegcétacoplan) dans le traitement de la C3G et de la IC-MPGN primaire
09/07/2026
Cette recommandation constitue une avancée majeure vers l’amélioration de l’accès aux soins pour les Canadiens atteints de néphropathies rares WALTHAM, Mass., 09 juill. 2026 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum [...]
Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
09/07/2026
Entered into global collaboration with Roche for bexobrutideg, with potential total payments of up to $2.3 billion, including $700 million upfront payment Co-development, co-commercialization collaboration includes [...]
Tilray Medical Announces Commercial Launch of Medical Cannabis in Panama, Expanding Patient Access Across Latin America
09/07/2026
Launch of Tilray Medical's first medical cannabis product in Panama strengthens the company's international footprint and supports broader access to regulated cannabinoid-based medicines PANAMA CITY, July 09, 2026 ( [...]
Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026
09/07/2026
WILMINGTON, Del., July 09, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the [...]
Canada’s Drug Agency Issues Positive Reimbursement Recommendation for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
09/07/2026
This recommendation represents an important step towards improving access for Canadians living with rare kidney diseases WALTHAM, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: [...]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/07/2026
BEDFORD, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today [...]
Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
09/07/2026
BANNOCKBURN, Ill., July 09, 2026 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced [...]
Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
09/07/2026
Data Safety Monitoring Committee completed initial review of sentinel dosing observations and recommended continued dosing in Cohort 1 - Dosing of additional patients in Cohort 1 is underway at sites in the US and [...]
Ipsen - Juin 2026 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
09/07/2026
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
GUERBET : Bilan semestriel du contrat de liquidité
09/07/2026
Bilan semestriel du contrat de liquidité Villepinte, le 9 juillet 2026 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, présente aujourd’hui le bilan [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 juin 2026
09/07/2026
DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l’article 222-12-5 du règlement général de l’AMF, les [...]
Ipsen - June 2026 - Monthly information relative to the total number of voting rights and shares composing the share capital
09/07/2026
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Breckenridge Distillery Launches Breck Vodka Seltzer, a Crisp New Ready-to-Drink Line Born in the Rockies
09/07/2026
The Award-Winning Colorado Craft Distillery Enters the Vodka Seltzer Category with Four Refreshing Flavors at 5% ABV BRECKENRIDGE, Colo., July 09, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery , one of the most- [...]
SRX Global Board of Directors Authorizes Stock Repurchase Plan of Up to 10 Million Shares or Up to 50% of its Shares Outstanding
09/07/2026
NORTH PALM BEACH, Fla., July 09, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company”, or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments [...]
Censozo Announces Online Educational Resources Focused on Wellness, Recovery Support, and Personal Growth
09/07/2026
Censozo expands access to educational content and self-help resources designed to support wellness awareness and personal development. Censozo online wellness and self-help resources. CHICAGO, July 09, 2026 (GLOBE [...]
Alkeus Pharmaceuticals Announces Gildeuretinol Data Presentations During the American Society of Retina Specialists (ASRS) 44th Annual Meeting July 15 - 18
09/07/2026
CAMBRIDGE, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced that data from [...]
The Lenny Peters Foundation and 20 Years of Transforming Lives and Communities
09/07/2026
High Point, NC, July 09, 2026 (GLOBE NEWSWIRE) -- The Lenny Peters Foundation is celebrating two decades of steadfast service, impactful giving and commitment to improving lives in North Carolina’s Piedmont Triad region [...]
Daré Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event
09/07/2026
Live video webcast on Tuesday, July 14 th , at 4:00 PM ET Register here SAN DIEGO, July 09, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on [...]
Amplia Announces Publication of New FAK Inhibitor Patent Application
09/07/2026
HIGHLIGHTS New patent application published covering chemically novel FAK inhibitors discovered by Amplia Application expands Amplia’s intellectual property portfolio supporting its FAK inhibitor program If granted, [...]

Pages